Abstract
To the Editor: We read with interest the paper by Hung et al.[1] “Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan”. The authors found an odds ratio of 5.6 (95% CI 3.33–9.46) for developing acute pancreatitis in subjects taking celecoxib compared with non-users. Their study was not designed to assess whether the coxib associated with a different risk of pancreatitis than non-selective non-steroidal anti-inflammatory drugs (nsNSAIDs).
Original language | English |
---|---|
Pages (from-to) | 1053-1054 |
Number of pages | 2 |
Journal | American Journal of Gastroenterology |
Volume | 113 |
DOIs | |
Publication status | Published - 2018 |
Keywords
- celecoxib
- pancreatitis